School of Medicine

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 30%
3. Population 28%
4. Cohort Studies 27%
5. Stroke 25%
6. Meta-Analysis 25%
7. Therapeutics 24%
8. Apoptosis 23%
9. Confidence Intervals 21%
10. Systematic Reviews 16%
11. Proteins 16%
12. Randomized Controlled Trials 15%
13. Odds Ratio 15%
14. Wounds and Injuries 15%
15. Mortality 14%
16. Lung 13%
17. Hepatocellular Carcinoma 13%
18. Genes 13%
19. Neoplasm Metastasis 13%
20. In Vitro Techniques 13%
21. Breast Neoplasms 13%
22. Arsenic 13%
23. Chronic Renal Insufficiency 13%
24. Kidney 13%
25. Databases 12%
26. Colorectal Neoplasms 12%
27. Inflammation 12%
28. Serum 12%
29. Autophagy 11%
30. Lipopolysaccharides 11%
31. Incidence 11%
32. Down-Regulation 11%
33. Reactive Oxygen Species 11%
34. Pharmaceutical Preparations 10%
35. Growth 10%
36. Survival 10%
37. National Health Programs 10%
38. Phosphorylation 10%
39. Endothelial Cells 9%
40. Macrophages 9%
41. Brain 9%
42. Blood Platelets 9%
43. Oxidative Stress 9%
44. Biomarkers 9%
45. Liver 8%
46. Retrospective Studies 8%
47. Carcinoma 8%
48. Traumatic Brain Injury 8%
49. Nitric Oxide 8%
50. Renal Dialysis 8%
51. Atrial Fibrillation 8%
52. Up-Regulation 8%
53. Lung Neoplasms 8%
54. Gene Expression 8%
55. Elderly 8%
56. MicroRNAs 8%
57. Child 8%
58. Glucose 8%
59. Metabolic Syndrome 8%
60. Prostatic Neoplasms 8%
61. Antioxidants 8%
62. Glioblastoma 8%
63. Bipolar Disorder 8%
64. Recurrence 7%
65. Cytokines 7%
66. Pain 7%
67. Nanoparticles 7%
68. Cardiac Myocytes 7%
69. Heme Oxygenase-1 7%
70. Cell Proliferation 7%
71. Infections 7%
72. Hypertension 7%
73. Bone and Bones 7%
74. Schizophrenia 7%
75. Parkinson Disease 7%
76. Messenger RNA 7%
77. Blood Pressure 7%
78. Cell Movement 7%
79. Tuberculosis 7%
80. Control Groups 7%
81. Calcium 7%
82. Drug Therapy 7%
83. Fibrosis 7%
84. Type 2 Diabetes Mellitus 7%
85. Logistic Models 7%
86. Skin 6%
87. Non-Small Cell Lung Carcinoma 6%
88. Dementia 6%
89. Safety 6%
90. Case-Control Studies 6%
91. Cell Line 6%
92. Exercise 6%
93. Magnetic Resonance Imaging 6%
94. ErbB Receptors 6%
95. Colonic Neoplasms 6%
96. Quality of Life 6%
97. Sepsis 6%
98. Cell Death 6%
99. Pulmonary Veins 6%
100. Catenins 6%